Skip to content
Home/Companies/Healthcare/Janvier Labs
Janvier Labs

Janvier Labs

Healthcare·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Janvier Labs?

Janvier Labs is a French Healthcare company, currently owned by Merieux Equity Partners since 2022.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 3 · 2019 · Buyout

Key facts

HQFrance
SectorHealthcare
Websitejanvier-labs.com

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Exited 2025
PharmaFrance
to ARCHIMED
Dental Monitoring
Dental Monitoring
Active
HealthTechFrance· 2021
Domus VI
Domus VI
Active
HealthcareFrance· 2021
DomusVi
DomusVi
Active
HealthcareFrance· 2021
SERB Pharmaceuticals
SERB Pharmaceuticals
Active
PharmaBelgium· 2021
SWIXX BioPharma
SWIXX BioPharma
Exited 2026
PharmaSwitzerland· 2021
to SK Capital / Bain Capital Life Sciences

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Janvier Labs?

Janvier Labs is currently owned by Merieux Equity Partners, through Mérieux Participations 3, since 2022.

When did Merieux Equity Partners acquire Janvier Labs?

Merieux Equity Partners acquired Janvier Labs in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue